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then compared over 10 years following surgery. Mixed-
effects regressions for repeated measures were used to esti-
mate the effect of patient characteristics and type of surgery 
on PROMs.
Results Five-hundred and ninety UKAs were matched to 
the same number of TKAs. Receiving UKA rather than 
TKA was found to be associated with better scores for 
OKS, including both its pain and function components, 
and EQ-5D, with the differences expected to grow over 
time. UKA was also associated with an increased likeli-
hood of patients achieving a successful outcome, with an 
increased chance of attaining minimally clinically impor-
tant improvements in both OKS and EQ-5D, and an ‘excel-
lent’ OKS. In addition, for both procedures, patients aged 
between 60 and 70 and better pre-operative scores were 
associated with better post-operative outcomes.
Abstract 
Purpose  For patients with medial compartment arthritis 
who have failed non-operative treatment, either a total knee 
arthroplasty (TKA) or a unicompartmental knee arthro-
plasty (UKA) can be undertaken. This analysis considers 
how the choice between UKA and TKA affects long-term 
patient-reported outcome measures (PROMs).
Methods The Knee Arthroplasty Trial (KAT) and a cohort 
of patients who received a minimally invasive UKA pro-
vided data. Propensity score matching was used to identify 
comparable patients. Oxford Knee Score (OKS), its pain 
and function components, and the EuroQol 5 Domain (EQ-
5D) index, estimated on the basis of OKS responses, were 
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Conclusion Minimally invasive UKAs performed on 
patients with the appropriate indications led to better patient-
reported pain and function scores than TKAs performed on 
comparable patients. UKA can lead to better long-term qual-
ity of life than TKA and this should be considered alongside 
risk of revision when choosing between the procedures.
Level of evidence II.
Keywords Arthroplasty · Knee replacement · Knee 
prosthesis · Knee osteoarthritis
Introduction
For individuals with end-stage arthritis of the knee, joint 
replacement relieves pain and improves function [8]. In 
patients with anteromedial arthritis, either a total knee 
arthroplasty (TKA) or a unicompartmental knee arthroplasty 
(UKA) can be undertaken, where the entire joint or only the 
affected compartment are replaced, respectively [1, 33].
Patient-reported outcome measures (PROMs) capture 
patients’ perceptions of their own functional status and 
well-being. PROMs can focus on patients’ perceptions 
of their general health or of health related to specific dis-
eases or conditions [10]. While condition-specific measures 
may be more sensitive, generic measures are required for 
informing resource allocation decisions across a health sys-
tem [15, 25]. Since 2009, PROMs have been routinely col-
lected for all patients receiving a knee arthroplasty funded 
by the National Health Service (NHS) in England [12], 
with the condition-specific Oxford Knee Score (OKS) and 
the generic EuroQol 5 Domain (EQ-5D) recorded pre-oper-
atively and 6 months post-operatively. After six months, 
UKA has been found to result in better OKS and EQ-5D, 
with those receiving UKA more likely to achieve the very 
best outcomes [29]. Whether these improvements are main-
tained in the longer-term, however, is unknown.
The choice between UKA and TKA is likely to also 
have long-term implications for patient-reported health 
outcomes. Whether the observed differences at 6 months 
can be expected to be maintained into the future is as yet 
unclear. The aim of this study was therefore to compare 
the long-term PROMs of those patients receiving UKA and 
TKA. These findings will provide important evidence that, 
along with the existing literature on their revision rates, 
can inform clinical decision-making when faced with the 
choice between the alternative procedures.
Materials and methods
Patient-reported outcomes were compared following 
TKA, reported in the Knee Arthroplasty Trial (KAT) 
[35], and UKA, recorded for a cohort of patients who 
received a minimally invasive medial UKA [36, 37]. Pro-
pensity score matching was used to identify comparable 
patients based on their observed characteristics. OKS, its 
pain and function component scores, and EQ-5D (esti-
mated by a mapping algorithm based on OKS) were 
compared for the matched patients, and mixed-effects 
regressions for repeated measures were used to examine 
the effect of surgical choice and patient characteristics 
on PROMs.
Setting and participants
Data were obtained from two prospective cohorts of 
patients receiving TKA or UKA in the United Kingdom 
(UK) in which the authors of this study were involved.
KAT was a partial factorial, pragmatic, multicentre 
randomised controlled trial which considered whether or 
not to resurface the patella during TKA, whether to use a 
fixed or a mobile tibial bearing, and whether to use modu-
lar or all-polyethylene tibial components [35]. Patients 
were eligible for inclusion in the trial if a decision had 
been made to have primary knee arthroplasty surgery, but 
no particular type of operation was clearly indicated, and 
were randomised between July 1999 and January 2003. 
While UKA was included in the original design of the 
trial, this arm was terminated early due to the develop-
ment of the minimally invasive technique for implanting 
unicompartmental arthroplasties [35], and these patients 
were excluded from this analysis. No significant clini-
cal differences were found between the remaining patient 
groups, and so these patients were pooled in this analysis 
to provide an indication of outcomes following total knee 
arthroplasty.
A separate observational cohort provided evidence for 
outcomes following UKA [36, 37]. These patients received 
the first 1000 phase 3 Oxford medial unicompartmental 
knee arthroplasties using a minimally invasive technique 
and met the recommended indications for the procedure 
[18]. These procedures were performed by two surgeons 
with patients followed prospectively in a dedicated research 
clinic run by independent physiotherapists. A total of 818 
patients received these arthroplasties with 636 unilateral 
and 182 bilateral (22 of which were undertaken simulta-
neously), with knees implanted between June 1998 and 
March 2009.
The index operation for all patients was a primary 
knee arthroplasty, either unicompartmental or total. 
Patients were included in the analysis if they had OKS 
recorded pre-operatively and at least once in the 10 years 
following their procedure. Outcomes were censored from 
when patients were lost to follow-up, had a revision or 
died.
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Patient‑reported outcome measures and data collection
The Oxford Knee Score (OKS) is a validated questionnaire 
specifically developed to assess patients’ pain and function 
status after knee arthroplasty [11]. The questionnaire con-
sists of 12 questions, each with five responses on a Likert 
scale and scored from 0 (most severe pain or limited func-
tion) to 4 (no pain or functional limitation). An overall 
score ranges from 0 to 48, with 48 being the best [34]. OKS 
can be disaggregated into a ‘OKS pain component’ and a 
‘OKS functional component’ [19], with the pain compo-
nent informed by seven of the questions and the functional 
component based on the remaining five. The OKS pain 
component ranges from 0 to 28, while the OKS functional 
component ranges from 0 to 20, with higher sores indicat-
ing less pain and better function, respectively. An overall 
OKS of above 41 can be considered ‘excellent’, above 
34–41 as ‘good’, above 27–34 as ‘fair’, while 27 or below 
is a ‘poor’ score [23]. Meanwhile, the minimally clinically 
important change in OKS for a patient is 4 points [5].
Within the KAT study, OKS was reported by patients via 
postal questionnaires prior to surgery, three months after 
the operation and annually thereafter. Following a postal 
reminder, any patients who had not returned the question-
naire were contacted by telephone and offered the option of 
completing the questionnaire over the telephone. Similarly, 
the Oxford UKA cohort was sent OKS questionnaires pre- 
and post-surgery, and if they did not return a questionnaire, 
they were contacted by telephone and were able to com-
plete the questionnaire over the phone.
EQ-5D is a widely used generic measure of health-
related quality of life consisting of five questions on mobil-
ity, self-care, pain/discomfort, usual activities and anxiety/
depression. Each question had three response levels with 
health-state preferences, or utilities, derived for the UK 
population [13]. Utilities indicate the relative preference 
that individuals associate with different health states and 
range from −0.5 to 1, with one representing perfect health, 
zero indicating death and negative values denoting health 
states worse than death. The minimally clinically important 
change in EQ-5D is 0.074 [40].
EQ-5D was not collected for the Oxford UKA cohort 
and was therefore estimated based on OKS responses, with 
individuals’ responses to each OKS question used to pre-
dict their EQ-5D score via a mapping algorithm [9]. While 
EQ-5D was collected in KAT alongside OKS, to provide 
a fair comparison, EQ-5D scores were also mapped from 
OKS responses for KAT patients.
Confounders
Age at operation and gender were collected for both 
KAT and the UKA patients. As the association of age on 
outcome was nonlinear, we considered age according to 
the following categories used in the randomisation process 
in KAT study: <60 years; 60–69 years; 70–79 years and 
80 years or older.
Ethical approval
KAT received ethics approval from the Multicen-
tre Research Ethics Committee for Scotland (ref: 
MREC/98/0/100). Ethical approval for the follow-up of 
UKA patients was not required under NHS research gov-
ernance arrangements.
Statistical methods
Patients receiving a TKA in the KAT trial were expected 
to differ to those in the UKA cohort thus making any 
unadjusted comparison between the groups ill-advised. 
Propensity score matching was therefore used to control 
for potential selection bias. The matching was generated 
by a logistic regression with age at procedure, gender, the 
Oxford Knee Score pain and function components and 
EQ-5D at baseline used as predictors of treatment choice. 
One-to-one nearest neighbour matching without replace-
ment was then used, with a caliper of 0.2 SDs specified 
within which controls could be drawn [3]. Patient charac-
teristics were compared before and after matching, with 
standardised mean differences used to assess the success of 
matching (a standardised mean difference of <0.1 indicates 
a negligible difference in the mean of a covariate between 
treatment groups) [2].
Overall OKS, its pain component, its functional compo-
nent and mapped EQ-5D were compared for the two pro-
pensity score-matched treatment groups. Mean scores were 
estimated for each year, and bias-corrected and accelerated 
(BCa) confidence intervals were estimated through 2000 
bootstraps.
Mixed-effects regressions for repeated measures were 
used to estimate the effect of treatment choice on out-
comes over 10 years for the propensity score-matched 
patients, with random intercepts and fixed slope specified. 
This method takes into account incomplete follow-up data, 
without any imputation of missing values, and provides 
valid estimates of treatment effects under the assumption 
that such data are missing at random. Linear regressions 
were used with OKS, the OKS pain component, the OKS 
functional component and mapped EQ-5D as outcomes of 
interest. Logistic regressions were used to test for the effect 
of surgical choice on what could be considered as a suc-
cessful outcome. Regressions were estimated for whether 
post-operative OKS was ‘excellent’ (>41), ‘excellent’ or 
‘good’ (>34), or ‘excellent’, ‘good’ or ‘fair’ (>27) [23], 
whether the difference between post-operative OKS and 
 Knee Surg Sports Traumatol Arthrosc
1 3
EQ-5D scores exceeded or was equal to the minimally clin-
ically important difference (4 points for OKS and 0.074 for 
EQ-5D) [5, 40] and whether these scores were the same or 
improved. Each model adjusted for age at operation, gender 
and baseline PROMs. As baseline PROMs were highly cor-
related, only the baseline score for the outcome of interest 
in each model was included. The merit of including interac-
tion terms was tested through a comparison, using ANOVA, 
of models with and without interaction terms. Statistical 
significance was set at 5% (p < 0.05).
Due to inherent differences in study designs, the proportion 
of missing data could be expected to differ for KAT and the 
Oxford UKA cohort. If outcomes of those with missing data 
and those excluded from the analysis differed from those who 
were included, then findings would be biased. Therefore, the 
characteristics and outcomes of those eligible for inclusion in 
the analysis were compared with those who were excluded.
Except for the mapping of Oxford Knee Scores to 
EQ-5D, which was done in Stata 12 using the oks2eq com-
mand [38], data analysis was undertaken in R 3.3.0. Pro-
pensity score matching was implemented using the MatchIt 
package [20], and mixed-effect regressions were imple-
mented using the Lme4 package with the sjPlot used to 
summarise results [4, 32].
Sensitivity analysis
Two sensitivity analyses were undertaken to assess how 
robust the results of the study were to changes in analytic 
decisions. First, the analysis was repeated using an alter-
native approach to propensity score matching where the 
requirement that controls could only be drawn from a cali-
per of 0.2 SDs was removed. Second, as knee arthroplasties 
in the Oxford UKA cohort were performed by two expe-
rienced surgeons, the analysis was re-run with only knee 
arthroplasties in KAT done by a consultant or an associate 
specialist included.
Sample size consideration
Data collection was not designed for this analysis but, 
rather, data were collected to inform independent consider-
ations of alternative methods of TKA and patient outcomes 
following minimally invasive UKA. This analysis made use 
of all available data which satisfied the inclusion criteria.
Results
Study participants
A flow chart detailing further inclusion/exclusion of 
patients is presented in Fig. 1, with the characteristics of 
those eligible and ineligible for inclusion are described in 
Appendix 1 as Electronic Supplementary. Given the simi-
larity in outcomes between those eligible and ineligible, 
imputation of missing data was deemed to be unnecessary. 
Prior to propensity score matching, patients receiving UKA 
were more likely to be younger, male and to have better 
health status than those receiving TKA. After propensity 
score matching, with 590 UKAs matched to 590 TKAs, 
these characteristics were well balanced with standardised 
mean differences <0.1. Patient characteristics before and 
after matching are detailed in Table 1. Twenty-four (4.1%) 
TKAs and 23 (3.9%) UKAs were revised over the 10 years 
of follow-up, and any patient-reported outcomes following 
revision were censored from the analysis.
Patient‑reported outcomes
At one year following primary surgery, patients who 
received an UKA reported a mean OKS of 40.3 (95% CI 
39.5–41.0), while those who received a TKA reported a 
mean OKS of 35.9 (95% CI 35.0–37.6). Differences per-
sisted over the period of follow-up with those patients who 
received a UKA reporting a mean OKS of 39.2 (95% CI 
38.1–40.2) after 10 years, while those who received a TKA 
reported a mean OKS of 35.9 (95% CI 34.6–37.0). Appen-
dix 2 as Electronic Supplementary shows the mean values 
of observed OKS, its pain and function components, and 
the mapped EQ-5D for propensity score-matched UKA and 
TKA patients with their corresponding bootstrapped confi-
dence intervals.
Reported scores were better for UKA than TKA for 
both the OKS pain and function components, where higher 
scores indicate less pain and better function, respectively. 
At one year following surgery, patients with UKA reported 
on average 23.8 (23.3–24.2) for the pain component and 
16.5 (16.2–16.7) for the function component, while TKA 
patients reported 22.0 (21.5–22.5) for the pain component 
and 14.1 (13.8–14.5) for the function component. After 
10 years, scores for UKA patients were 23.6 (22.8–24.3) 
for the pain component and 15.3 (14.7–15.9) for the func-
tion component, while TKA patients reported 22.2 (21.5–
22.9) and 13.7 (13.2–14.3).
EQ-5D, mapped from these OKS scores, was estimated 
to be on average 0.82 (0.80–0.83) for UKA patients and 
0.74 (0.72–0.76) for TKA patients at the first year post-
surgery. After 10 years, EQ-5D for UKA patients was 0.78 
(0.76–0.8) and 0.74 (0.72–0.76) for TKA.
Factors associated with patient‑reported outcomes
Table 2 summarises the results from the mixed-effects 
linear regressions of OKS, its pain and function compo-
nents, and mapped EQ-5D scores. A statistically significant 
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interaction was found between surgery and years since sur-
gery for the linear regressions (Fig. 2). The provision of 
UKA rather than TKA was associated with statistically sig-
nificant increased scores for overall OKS, both of its pain 
and function components, and EQ-5D. While all scores for 
TKA patients are expected to fall over time, UKA scores 
are expected to fall to a lesser degree or, in the case of the 
OKS pain component, to improve. Based on regressions 
of PROMs recorded for year 1 (Appendix 4 as Electronic 
Supplementary), the provision of UKA rather than TKA 
was associated with an additional 4.1 points for OKS 
(p < 0.05), with an additional 1.9 (p < 0.05) points in the 
pain component and 1.6 (p < 0.05) for the function com-
ponent, while EQ-5D was estimated to be higher by 0.06 
Fig. 1  Flow chart of study 
inclusion
Table 1  Patient characteristics before and after matching
Standardised mean difference compares the difference in means in units of the pooled standard deviation
TKA total knee arthroplasty, UKA unicompartmental knee arthroplasty, SD standard deviation, IQ interquartile range
Before matching Standardised  
mean difference
After matching Standardised 
mean difference
TKA UKA TKA UKA
N 1980 675 590 590
Age (mean, SD) 70.4 (8.2) 66.8 (9.6) 0.40 67.59 (8.37) 67.66 (9.0) 0.01
Gender: male (n, %) 864 (44%) 350 (52%) 0.17 292 (49%) 293 (50%) 0.00
Pre-op OKS pain compo-
nent (mean, SD)
9.61 (4.6) 12.63 (5.2) 0.62 11.56 (5.2) 11.82 (4.8) 0.05
Pre-op OKS function com-
ponent (mean, SD)
8.57 (3.5) 11.95 (4.0) 0.89 10.9 (3.7) 11.19 (3.7) 0.08
Pre-op OKS (mean, SD) 18.18 (7.5) 24.59 (8.7) 0.79 22.46 (8.3) 23.03 (8.0) 0.07
Pre-op EQ-5D (median, IQ) 0.4 (0.2–0.6) 0.61 (0.4–0.7) 0.62 0.57 (0.3–0.7) 0.58 (0.3–0.7) 0.07
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(p < 0.01). At year 10, OKS for UKA was expected to be 
4.5 (p < 0.05) higher than for TKA, with a difference of 1.7 
(p < 0.05) for the pain component and 2.1 (p < 0.05) for the 
function component, and EQ-5D was expected to be 0.07 
(p < 0.05) higher for UKA. Table 3 details the results from 
the mixed-effects logistic regressions on the effect of surgi-
cal choice on patient-reported outcomes. The use of UKA 
was associated with greater odds of achieving a successful 
outcome.   
A number of patient factors were included in the mul-
tivariate regressions, with the full model specifications 
detailed in Appendixes 3 and 5 as Electronic Supplemen-
tary. Patients aged between 60 and 70 were associated with 
better OKS and EQ-5D for both UKA and TKA than those 
aged below 60 (−1.5, n.s., and −0.03, p < 0.05, respec-
tively), those aged 70–80 (−1.4 and −0.03, p < 0.05), and 
those older than 80 (−0.8 and −0.03, n.s.). For both UKA 
and TKA, male gender was associated with a better OKS 
Table 2  Effect of surgical choice and years since surgery on patient-reported outcome scores over 10 years following surgery
Estimated effect of surgical choice from mixed-effects linear regressions controlling for years since surgery, age group, gender and pre-operative 
scores (Appendix 3 as Electronic Supplementary). An interaction term between type of surgery and years since surgery was included in the 
model. The estimated effect associated with surgical choice is a product of the combination of these three coefficient estimates
n.s. not significant
* p < 0.05
OKS pain component 
(0 to 28)
OKS function  
component (0 to 20)
OKS (0 to 48) EQ-5D (−0.59 to 1)
Surgery (UKA) Estimate (95% CI) 1.7 (1.1 to 2.4)* 2.2 (1.8 to 2.7)* 4.0 (3.1 to 5.0)* 0.07 (0.05 to 0.09)*
Years since surgery Estimate (95% CI) −0.1 (−0.1 to −0.1)* −0.1 (−0.1 to −0.1)* −0.2 (−0.3 to −0.1)* −0.00 (−0.01 to −0.00)*
Surgery (UKA)* 
Years since surgery
Estimate (95% CI) 0.1 (0.1 to 0.2)* 0.0 (−0.0 to 0.1)n.s. 0.1 (0.0 to 0.2)* 0.00 (−0.00 to 0.00)n.s
Fig. 2  Marginal effect of treatment and time on patient-reported outcomes from mixed-effects regressions. A higher score indicates better out-
comes for each measure. Yearly point estimates with shaded areas reflecting 95% confidence intervals
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function component (0.2), but a worse OKS pain compo-
nent (−0.3) and overall OKS (−0.2) and no difference in 
EQ-5D, although none of these differences were found 
to be statistically significant. Better pre-operative scores 
were associated with better post-operative scores for both 
OKS (0.4, p < 0.05), including the pain (0.3, p < 0.05) and 
function (0.5, p < 0.05) components, and EQ-5D (0.27, 
p < 0.05). These indicate that, for example, a one-point 
higher score for OKS pre-operatively is associated with on 
average a 0.4-point higher score post-operatively.
Sensitivity analysis
Propensity score matching without the requirement that 
controls could only be drawn from a caliper of 0.2 SDs 
allowed all 678 eligible UKAs to be included in the anal-
ysis. Matched UKA and TKA patients were not well bal-
anced with only gender and age having a standardised 
mean difference of <0.1 (see Appendix 6, Table A.6.1 as 
Electronic Supplementary). The results from the analysis 
were similar to those in the primary analysis (see Appendix 
6, Table A.6.2 as Electronic Supplementary).
Only including those knee arthroplasties undertaken 
by a consultant or associate specialist in KAT led to 1428 
KAT patients being eligible for inclusion (see Appendix 
7, Table A.7.1 as Electronic Supplementary). After repeat-
ing the propensity score matching, this additional restric-
tion did not have any substantial effect on the results of the 
analysis with the provision of UKA associated with similar 
improvements in PROMs as found in the base case analysis 
(see Appendix 7, Table A.7.2 as Electronic Supplementary).
Discussion
The most important finding of the study is that those 
patients who received one of the first 1000 phase 3 Oxford 
medial unicompartmental knee arthroplasties using a 
minimally invasive technique have reported better patient-
reported outcomes than comparable patients who received 
a total knee arthroplasty as part of the Knee Arthroplasty 
Trial. These differences in outcomes were sustained across 
10 years following the procedures. While the differences in 
observed scores decreased over time, after controlling for 
age, gender and baseline scores using multivariate regres-
sion models, the differences in outcomes between UKA 
and TKA are in fact estimated to grow over time. While all 
scores for TKA patients are expected to fall, UKA scores 
are expected to fall to a lesser degree or, in the case of the 
OKS pain component, to improve.
The difference in OKS is driven by greater improve-
ments in both its pain and function components. As would 
be expected, given the effects of normal ageing, OKS func-
tion component scores fall over time [21, 41]. However, 
these reductions in OKS function component scores are 
more pronounced for TKA patients. In addition, OKS pain 
component scores, which are less influenced by the age-
ing process [7], diverge with UKA pain scores improving 
over time while those of TKA worsen. The provision of 
UKA rather than TKA is also associated with an increased 
likelihood of a successful outcome, with receiving UKA 
more likely to achieve the minimally clinically important 
improvements in both OKS and EQ-5D, and an ‘excellent’ 
post-operative OKS.
The difference in outcomes estimated here exceeds that 
observed for routinely collected NHS PROMs after six 
months, where UKA was associated with an adjusted mean 
difference of 1.5 for OKS and 0.02 for EQ-5D, and odds 
ratios of 1.3 for achieving a minimally clinically impor-
tant difference in OKS and 1.6 for an ‘excellent’ OKS [29]. 
This increased treatment effect is likely due to the charac-
teristics of the UKAs included here, which were performed 
by surgeons with a high usage and caseload of UKA at a 
high-volume centre, all of which has been found to be asso-
ciated with better outcomes [6, 28, 30].
For both the UKA and TKA patients for this analysis, 
better pre-operative scores are associated with better post-
operative OKS. This is consistent with previous research on 
those receiving both UKA and TKA [21, 22, 27].
The estimated effects of gender on PROMs are mixed 
with no statistically significant differences found. Previ-
ous findings for the effect of gender are also mixed as while 
Table 3  Effect of surgical choice on the odds of attaining successful 
patient-reported outcomes over 10 years following surgery
OR odds ratio (OR) based on mixed-effects logistic regression con-
trolling for years since surgery, age group, gender and pre-operative 
scores (Appendix 5 as Electronic Supplementary). OKS categories 
are based on absolute scores, while change in OKS and EQ-5D com-
pares patients’ post-operative scores with their pre-operative score
MCID Minimally clinically important difference, OKS Oxford knee 
score, UKA unicompartmental knee arthroplasty, CI confidence inter-
vals
* p < 0.05
Surgery (UKA) OR (95% CI)
OKS categories
‘Excellent’ (>41) 4.6 (3.2–6.5)*
‘Excellent’ or ‘good’ (>34) 3.8 (2.5–5.9)*
‘Excellent’, ‘good’ or ‘fair’ (>27) 3.5 (2.0–6.0)*
Change in OKS
Achieve MCID (≥4) 2.9 (1.8–4.7)*
No change or improvement (≥0) 3.0 (1.7–5.5)*
Change in EQ-5D
Achieve MCID (≥0.074) 2.5 (1.6–3.8)*
No change or improvement (≥0) 2.1 (1.4–3.6)*
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being male has been found to be associated with a lower 
OKS following TKA, with the difference attributed to the 
function component [22], being male has been found to be 
associated with better scores following UKA [27].
PROMs were found in our analysis to be better for those 
aged between 60 and 70, with both younger and older 
patients reporting worse outcomes. Previous estimates for 
the effect of age on outcomes have been mixed, with one 
study finding no relationship [17], others finding that older 
age to be related with poorer outcomes [14, 16, 22, 24, 31], 
while two others found outcomes to peak among those aged 
between 60 and 80 and for those aged 75, respectively [21, 
27]. The findings from this analysis are in line with these lat-
ter two studies.
This analysis is informed by evidence from two patient 
cohorts, with KAT providing evidence on outcomes 
following TKA, while a cohort of 1000 patients who 
received a minimally invasive phase 3 Oxford medial 
UKA provides evidence for UKA. Both studies were 
rigorously undertaken, and a number of publications 
have reported results from them independently [35–37]. 
PROMs were reported in each study over 10 years fol-
lowing knee arthroplasty, and synthesising the studies has 
allowed us to provide the first, to our knowledge, com-
parison of long-term patient-reported outcome measures 
following UKA and TKA.
Patient characteristics differed across the studies, 
with those in the UKA cohort more likely to be younger, 
male and to report better pre-operative PROMs. This is 
consistent with current provision in the NHS [26, 29]. 
Propensity score matching was used here to achieve 
similar distributions in observed baseline covariates so 
as to minimise potential confounding. However, while 
differences in observed patient characteristics were 
minimised, differences may have remained in unob-
served characteristics. In particular, patient comorbidi-
ties and pre-operative radiographs were not included 
and although both can be expected to be correlated 
with baseline PROMs, and so controlled for to some 
degree, imbalances in these may well remain. Moreo-
ver, differences in health care not associated with treat-
ment choice, such as access to physiotherapy, may have 
existed between the groups.
As well as differences in patient characteristics, differ-
ences in the characteristics of the surgeons in the two stud-
ies could also lead to differences in treatment effects lim-
iting the generalisability of the results. Knee arthroplasties 
for the Oxford UKA cohort were performed by two experi-
enced surgeons, while those done in KAT were performed 
by surgeons with a range of experience. Limiting our selec-
tion criteria to include only TKAs undertaken by a consult-
ant or associate specialist in KAT did not have any substan-
tial effect on the results of the analysis. It can be expected, 
however, that if the UKA cohort could be expanded to 
include low usage surgeons, UKA outcomes would fall [30].
The studies used to inform this analysis also differed in 
their proportions of missing data. In particular, while 6% 
of KAT patients were excluded on the basis of missing pre-
operative scores, 28% of the Oxford UKA cohort were. 
These differing rates could lead to bias if missingness was 
not completely at random. If, for example, those excluded 
were more likely to have worse outcomes, then the esti-
mated effect of UKA would be exaggerated. However, it 
was observed that excluded patients had similar characteris-
tics at baseline and similar outcomes than included patients. 
Based on this finding, missing pre-operative OKS are not 
expected to lead to bias, although they can be expected to 
have widened the uncertainty surrounding estimates of the 
effects of patient characteristics and type of surgery [39].
Conclusion
Minimally invasive UKAs performed on patients with the 
appropriate indications resulted in better patient-reported 
health outcomes than total knee arthroplasties performed 
on similar patients. Differences in patient-reported out-
comes were maintained over 10 years demonstrating the 
long-term impact of the choice of surgical procedure on 
health outcomes.
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